In this issue:
Upfront immunotherapy extends survival in advanced oesophageal cancer
Mixed results for nivolumab in HER2-negative gastric cancer
Salvage PRRT extends PFS in enteropancreatic NETs
Eating red meat after a colon cancer diagnosis doesn’t impact
outcomes
No benefit to adding atezolizumab to capecitabine/bevacizumab in refractory mCRC
Adjuvant trastuzumab fails to extend DFS in HER2-positive oesophageal cancer
Anti-HER2 doublet combination active in relapsed/refractory HER2-mutated NSCLC
Single-agent trastuzumab emtansine for HER2-mutated NSCLC
Poziotinib promising for HER2 exon 20-mutated NSCLC
ctDNA prognostic for outcome in metastatic pancreatic cancer
Please login below to download this issue (PDF)